COVID-19: First data shows BioNTech-Pfizer ′100% effective′ in young teenagers | Science | In-depth reporting on science and technology | DW | 31.03.2021

Visit the new DW website

Take a look at the beta version of dw.com. We're not done yet! Your opinion can help us make it better.

  1. Inhalt
  2. Navigation
  3. Weitere Inhalte
  4. Metanavigation
  5. Suche
  6. Choose from 30 Languages

Science

COVID-19: First data shows BioNTech-Pfizer '100% effective' in young teenagers

Initial data (that has yet to be peer reviewed) suggests the BioNTech-Pfizer vaccine may work even better for young teens than it does for adults — due to an even stronger antibody reaction. The announcement came a day after Germany halted the use of AstraZeneca for anyone under 60.

Listen to audio 08:27